| Aug 15 |
Bears are Losing Control Over Seres Therapeutics (MCRB), Here's Why It's a 'Buy' Now
|
| Aug 14 |
Q2 2024 Seres Therapeutics Inc Earnings Call
|
| Aug 13 |
Seres Therapeutics, Inc. (MCRB) Q2 2024 Earnings Call Transcript
|
| Aug 13 |
Seres Therapeutics: Q2 Earnings Snapshot
|
| Aug 13 |
Seres Therapeutics GAAP EPS of -$0.22 beats by $0.06
|
| Aug 13 |
Seres Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Updates
|
| Aug 12 |
Seres Therapeutics Q2 2024 Earnings Preview
|
| Aug 6 |
Nestlé agrees to buy microbiome therapy Vowst from Seres
|
| Aug 6 |
Seres Therapeutics to Announce Second Quarter 2024 Financial Results and Business Update on August 13, 2024
|
| Aug 6 |
Seres Therapeutics Announces Signing of VOWST™ Asset Purchase Agreement with Nestlé Health Science
|
